Back to SO Squarepoint Ops LLC

IOVAIOVA
30 quarters

Position history for SOSquarepoint Ops LLC's holdings in IOVANCE BIOTHERAPEUTICS INC

Yes. Squarepoint Ops holds 325,582 shares of IOVA (Iovance Biotherapeutics), worth $1.4M, as of its Q2 2026 13F filing. It reduced the position by 706,586 shares (-68.5%) from Q1 2026. Squarepoint Ops has held IOVA since Q2 2024, across 9 quarterly 13F filings.

Current Value

$1.4M

Current Shares

325,582

Total Value Change

-$561,579

Total Shares Change

+109,130

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
325,582
-68.5%
$1.4M0.0%$4.16
0
2026-Q1
Increased
1M
+4028.5%
$3.6M0.0%$3.51
43
2025-Q4
Decreased
25,001
-42.9%
$68,2530.0%$2.73
0
2025-Q3
Decreased
43,758
-94.9%
$94,9550.0%$2.17
0
2025-Q2
Increased
856,569
+115.2%
$1.5M0.0%$1.72
41
2025-Q1
Increased
398,029
+161.3%
$1.3M0.0%$3.33
41
2024-Q4
Decreased
152,342
-50.4%
$1.1M0.0%$7.40
0
2024-Q3
Increased
307,384
+19.4%
$2.9M0.0%$9.39
31
2024-Q2
New
257,543
-
$2.1M0.0%$8.02
36
2023-Q4
Exited
0
-100.0%
$00.0%$8.13
0
2023-Q3
New
128,541
-
$584,8620.0%$4.55
34
2023-Q2
Exited
0
-100.0%
$00.0%$7.04
0
2023-Q1
New
41,632
-
$254,3720.0%$6.11
32
2022-Q4
Exited
0
-100.0%
$00.0%$6.39
0
2022-Q3
New
368,310
-
$3.5M0.0%$9.58
37
2022-Q2
Exited
0
-100.0%
$00.0%$11.04
0
2022-Q1
Decreased
21,546
-82.6%
$359,0000.0%$16.65
0
2021-Q4
Increased
123,591
+276.1%
$2.4M0.0%$19.09
42
2021-Q3
Increased
32,861
+42.0%
$810,0000.0%$24.66
33
2021-Q2
Decreased
23,134
-36.1%
$602,0000.0%$26.02
0
2021-Q1
New
36,227
-
$1.1M0.0%$31.66
35
2020-Q4
Exited
0
-100.0%
$00.0%$46.40
0
2020-Q3
Decreased
12,640
-90.4%
$416,0000.0%$32.92
0
2020-Q2
Increased
131,770
+1835.0%
$3.6M0.1%$27.45
43
2020-Q1
Decreased
6,810
-86.5%
$204,0000.0%$29.94
0
2019-Q4
Increased
50,320
+44.9%
$1.4M0.0%$27.68
34
2019-Q3
Decreased
34,728
-36.3%
$632,0000.0%$18.20
0
2019-Q2
Decreased
54,515
-83.8%
$1.3M0.0%$24.52
0
2019-Q1
Increased
336,627
+55.5%
$3.2M0.0%$9.51
37
2018-Q4
First report
216,452
-
$1.9M0.0%$8.85
0

Other major holders of IOVA: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FRANKLIN TEMPLETON INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used